Search research articles
Contact Us
Filters
Showing results (121-130 of 156) with videos related to
Page
of 16
Sort By:
Leukemia Research Reports
|
December 28, 2013
Lenalidomide monotherapy and in combination with cytarabine, daunorubicin and etoposide for high-risk myelodysplasia and acute myeloid leukaemia with chromosome 5 abnormalities
M Dennis, D Culligan, D Karamitros, et al.
British Journal of Haematology
|
May 3, 2000
Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity
G M Cull, A P Haynes, J L Byrne, et al.
Leukemia
|
June 8, 2018
A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial
A K Burnett, R K Hills, O J Nielsen, et al.
Leukemia
|
October 27, 2006
DNA repair contributes to the drug-resistant phenotype of primary acute myeloid leukaemia cells with FLT3 internal tandem duplications and is reversed by the FLT3 inhibitor PKC412
C H Seedhouse, H M Hunter, B Lloyd-Lewis, et al.
Bone Marrow Transplantation
|
September 11, 2001
Accelerated telomere shortening following allogeneic transplantation is independent of the cell source and occurs within the first year post transplant
J D Robertson, N G Testa, N H Russell, et al.
Bone Marrow Transplantation
|
October 26, 2005
Management of chronic myeloid leukaemia in relapse following donor lymphocyte infusion induced remission: a retrospective study of the Clinical Trials Committee of the British Society of Blood & Marrow Transplantation (BSBMT)
M Cummins, K Cwynarski, S Marktel, et al.
Bone Marrow Transplantation
|
January 1, 1997
Allogeneic peripheral blood stem cell transplantation for haematological malignancies--an analysis of kinetics of engraftment and GVHD risk
G Miflin, N H Russell, R M Hutchinson, et al.
Cytotherapy
|
June 5, 2002
An analysis of the effect of chronic GvHD on relapse and survival following allogeneic PBSC transplantation
G Miflin, N H Russell, I Franklin, et al.
Plos One
|
January 13, 2022
Comparative analysis of DNA extraction and PCR product purification methods for cervicovaginal microbiome analysis using cpn60 microbial profiling
Elinor Shvartsman, Meika E I Richmond, John J Schellenberg, et al.
Leukemia
|
September 12, 2012
The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: results from the LRF AML14 and NCRI AML16 pick-a-winner comparison
A K Burnett, R K Hills, A E Hunter, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 156) with videos related to
Sort By:
Page
of 16
Leukemia Research Reports
|
December 28, 2013
Lenalidomide monotherapy and in combination with cytarabine, daunorubicin and etoposide for high-risk myelodysplasia and acute myeloid leukaemia with chromosome 5 abnormalities
M Dennis, D Culligan, D Karamitros, et al.
British Journal of Haematology
|
May 3, 2000
Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity
G M Cull, A P Haynes, J L Byrne, et al.
Leukemia
|
June 8, 2018
A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial
A K Burnett, R K Hills, O J Nielsen, et al.
Leukemia
|
October 27, 2006
DNA repair contributes to the drug-resistant phenotype of primary acute myeloid leukaemia cells with FLT3 internal tandem duplications and is reversed by the FLT3 inhibitor PKC412
C H Seedhouse, H M Hunter, B Lloyd-Lewis, et al.
Bone Marrow Transplantation
|
September 11, 2001
Accelerated telomere shortening following allogeneic transplantation is independent of the cell source and occurs within the first year post transplant
J D Robertson, N G Testa, N H Russell, et al.
Bone Marrow Transplantation
|
October 26, 2005
Management of chronic myeloid leukaemia in relapse following donor lymphocyte infusion induced remission: a retrospective study of the Clinical Trials Committee of the British Society of Blood & Marrow Transplantation (BSBMT)
M Cummins, K Cwynarski, S Marktel, et al.
Bone Marrow Transplantation
|
January 1, 1997
Allogeneic peripheral blood stem cell transplantation for haematological malignancies--an analysis of kinetics of engraftment and GVHD risk
G Miflin, N H Russell, R M Hutchinson, et al.
Cytotherapy
|
June 5, 2002
An analysis of the effect of chronic GvHD on relapse and survival following allogeneic PBSC transplantation
G Miflin, N H Russell, I Franklin, et al.
Plos One
|
January 13, 2022
Comparative analysis of DNA extraction and PCR product purification methods for cervicovaginal microbiome analysis using cpn60 microbial profiling
Elinor Shvartsman, Meika E I Richmond, John J Schellenberg, et al.
Leukemia
|
September 12, 2012
The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: results from the LRF AML14 and NCRI AML16 pick-a-winner comparison
A K Burnett, R K Hills, A E Hunter, et al.
Page
of 16